Home Tools

AZD-1480

Catalog No. T3069 CAS 935666-88-9

AZD1480 is a novel ATP-competitive JAK2 inhibitor (IC50: 0.26 nM), selectivity act against Tyk2 and JAK3, and to a smaller extent against JAK1. AZD1480 has been used in trials studying the treatment of Solid Malignancies, Post-Polycythaemia Vera, Primary Myelofibrosis (PMF), and Essential Thrombocythaemia Myelofibrosis.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.

AZD-1480, CAS 935666-88-9

Pack Size	Availability	Price/USD
5 mg	In stock	$ 52.00
10 mg	In stock	$ 81.00
25 mg	In stock	$ 143.00
50 mg	In stock	Inquiry
1 mL * 10 mM (in DMSO)	In stock	$ 54.00

Bulk Inquiry

Select Batch

Purity: 98.55%

Purity: 98.25%

Purity: 97.5%

Biological Description

Chemical Properties

Storage & Solubility Information

Description	AZD1480 is a novel ATP-competitive JAK2 inhibitor (IC50: 0.26 nM), selectivity act against Tyk2 and JAK3, and to a smaller extent against JAK1. AZD1480 has been used in trials studying the treatment of Solid Malignancies, Post-Polycythaemia Vera, Primary Myelofibrosis (PMF), and Essential Thrombocythaemia Myelofibrosis.
Targets&IC50	JAK2:0.26 nM
In vitro	AZD1480 inhibits the growth of subcutaneous xenograft tumors and extends the lifespan of mice carrying intracranial malignant gliomas by inhibiting the activity of STAT3, indicating that AZD1480's inhibition of the JAK/STAT3 pathway can be utilized in research targeting the treatment of patients with intracranial malignant gliomas. Furthermore, AZD1480 suppresses STAT3 phosphorylation in human solid tumor and multiple myeloma models, reduces angiogenesis and metabolism in human xenograft models, and demonstrates inhibitory effects on the growth of human solid tumors with active STAT. Additionally, AZD1480 inhibits lung metastasis and pulmonary infiltration of tumors in bone marrow cells.
In vivo	AZD1480, by affecting the microenvironment of tumors, can inhibit local metastasis and angiogenesis. As an effective inhibitor of JAK2, it suppresses the growth and survival of human multiple myeloma cells, as well as inhibits FGFR3 and STAT3 signaling and downstream targets, including Cyclin D2. At low micromolar concentrations, AZD1480 induces apoptosis and inhibits cell proliferation in myeloma cell lines. Moreover, at 5 μM, it induces cell cycle arrest at the G2/M phase and cell death through inhibition of Aurora kinases. In both human and murine glioma cells, AZD1480 effectively inhibits constitutive and inducible phosphorylation of JAK1/2 and STAT-3, thereby reducing cell proliferation and inducing apoptosis.
Kinase Assay	kinase assays: Inhibition studies of AZD1480 are performed using recombinant Jak1, Jak2, or Jak3 under buffer conditions of 50 mM HEPES pH 7.3, 1 mM DTT, 0.01% Tween-20, 50 mM/ml BSA, and 10 mM MgCl2. Jak3 enzyme is expressed as N-terminal GST fusion in insect cells and purified by glutathione-affinity and size-exclusion chromatographies. Enzymes are assayed in the presence of AZD1480 (10 point dose response, in triplicate, from 8.3 μM to 0.3 nM in half-log dilution steps) using 1.5 μM peptide substrate (Jak1: FITC-C6-KKHTDDGYMPMSPGVA-NH2, Jak2 and Jak3: FAM-SRCtide) and screened under their respective ATP Km (Jak1: 55 μM, Jak2: 15 μM, Jak3: 3 μM) and approximated physiological ATP concentration of 5 mM. Phosphorylated and unphosphorylated peptides are separated and quantified by a Caliper LC3000 system for calculating percent inhibition.
Cell Research	Renca or 786-O cells are suspended in DMEM medium with 5% FBS , and seeded in 96-well plates (5×103 per well) to allow adhesion and then treated with DMSO or AZD1480 for 48 hours. Cell viability is determined by MTS assay. Absorbance at 490 nm is measured with Mikrotek Laborsysteme. Mouse endothelial cells and splenic CD11b+/c- myeloid cells are enriched from tumor-bearing mice,and cultured in 5% FBS RPMI-1640 medium. HUVECs are cultured on collagen 1–coated plates in complete medium. All cells are treated with DMSO and AZD1480 at various doses for 24 hours. Cell viability is determined by counting cell number manually. All the experiments are repeated 3 times. (Only for Reference)

Molecular Weight	348.77
Formula	C14H14ClFN8
CAS No.	935666-88-9

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

Ethanol: < 1 mg/mL (insoluble or slightly soluble)

H2O: < 1 mg/mL (insoluble or slightly soluble)

DMSO: 64 mg/mL (183.5 mM)

References and Literature

1. E Derenzini, et al. Blood Cancer J, 2011, 1(12), e46. 2. Scuto A, et al. Leukemia, 2011, 25(3), 538-50. 3. McFarland BC,et al. Cancer Ther, 2011, 10(12), 2384-93. 4. Xin H, et al. Cancer Res, 2011, 71(21), 6601-10. 5. Hedvat M, et al. Cancer Cell, 2009, 16(6), 487-97. 6. Ni J, et al. Tyrosine receptor kinase B is a drug target in astrocytomas. Neuro Oncol. 2017 Jan;19(1):22-30. 7. Yang, Tianfeng, Xianpeng Shi, Yuan Kang, Man Zhu, Mengying Fan, Dongdong Zhang, and Yanmin Zhang. Novel compounds TAD-1822-7-F2 and F5 inhibited HeLa cells growth through the JAK/Stat signaling pathway [J]. Biomedicine & Pharmacotherapy . 2018 Jul;103:118-126.

Citations

1. Yang T, Shi X, Kang Y, et al. Novel compounds TAD-1822-7-F2 and F5 inhibited HeLa cells growth through the JAK/Stat signaling pathway. Biochemical & Pharmacology. 2018, 103: 118-126 2. Hu Z, Sui Q, Jin X, et al.IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma.Journal of Experimental & Clinical Cancer Research.2024, 43(1): 63.

Related compound libraries

This product is contained In the following compound libraries：

Anti-Cancer Drug Library Inhibitor Library Anti-Cancer Clinical Compound Library Drug Repurposing Compound Library Anti-Cancer Active Compound Library Kinase Inhibitor Library Bioactive Compounds Library Max Anti-Lung Cancer Compound Library Immunology/Inflammation Compound Library Anti-Aging Compound Library

Related Products

Related compounds with same targets

Momelotinib sulfate Filgotinib JAK-IN-33 JAK-IN-5 JAK3-IN-6 Gandotinib JBJ-04-125-02 Upadacitinib

Dose Conversion

You can also refer to dose conversion for different animals. More

In vivo Formulation Calculator (Clear solution)

Step One: Enter information below

Dosage

mg/kg

Average weight of animals

Dosing volume per animal

Number of animals

Step Two: Enter the in vivo formulation

% DMSO+

% +

% Tween 80+

% ddH₂O

%DMSO+

Calculate Reset

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO (Master liquid concentration mg/mL)，Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation：Take μL DMSO master liquid, next add μL PEG300， mix and clarify, next add μL Tween 80，mix and clarify, next add μL ddH₂O, mix and clarify.

Note:

Be sure to add the solvent(s) in order. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.

Calculator

Molarity Calculator

Dilution Calculator

Reconstitution Calculation

Molecular Weight Calculator

Mass

Concentration

Volume

Molecular Weight

Molarity Calculator allows you to calculate the

Mass of a compound required to prepare a solution of known volume and concentration
Volume of solution required to dissolve a compound of known mass to a desired concentration
Concentration of a solution resulting from a known mass of compound in a specific volume

See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

Concentration (Start)

Volume (Start)

Concentration (End)

Volume (End)

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Molecule Formula

Molecular Weight g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

AZD-1480 935666-88-9 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling Stem Cells JAK inhibit Inhibitor Janus kinase AZD1480 AZD 1480 inhibitor

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.